Congressional Leaders Urge President Biden and the Department of Defense to Consider Polymetallic Nodules for U.S. Critical Mineral Supplies and National Security 31-07-2023, 19:00

Blockchain E-learning Platform, Bitcamp, is Transfiguring 9-03-2023, 09:03

Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26